Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Raw Materials (2016 - 2019)

Historic Raw Materials for Tandem Diabetes Care (TNDM) over the last 6 years, with Q1 2019 value amounting to $9.6 million.

  • Tandem Diabetes Care's Raw Materials fell 779.22% to $9.6 million in Q1 2019 from the same period last year, while for Mar 2019 it was $9.6 million, marking a year-over-year decrease of 779.22%. This contributed to the annual value of $6.6 million for FY2018, which is 3588.3% down from last year.
  • Tandem Diabetes Care's Raw Materials amounted to $9.6 million in Q1 2019, which was down 779.22% from $6.6 million recorded in Q4 2018.
  • In the past 5 years, Tandem Diabetes Care's Raw Materials registered a high of $12.1 million during Q2 2016, and its lowest value of $6.6 million during Q4 2018.
  • Its 5-year average for Raw Materials is $9.9 million, with a median of $10.0 million in 2016.
  • As far as peak fluctuations go, Tandem Diabetes Care's Raw Materials soared by 4969.65% in 2015, and later crashed by 3588.3% in 2018.
  • Over the past 5 years, Tandem Diabetes Care's Raw Materials (Quarter) stood at $10.6 million in 2015, then fell by 11.61% to $9.4 million in 2016, then grew by 10.17% to $10.3 million in 2017, then crashed by 35.88% to $6.6 million in 2018, then soared by 44.74% to $9.6 million in 2019.
  • Its last three reported values are $9.6 million in Q1 2019, $6.6 million for Q4 2018, and $8.6 million during Q3 2018.